Skip to main content

Table 1 The four gene panels designed and adopted in this study

From: Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management

 

Genes

Number of amplicons

Cumulative target (bps)

Number of samples

Parkinson panel

GBA, ATP13A2, PARK7, PINK1, EIF4G1, UCHL1, SNCA, PARK2, LRRK2, VPS35

368

76,146

54

COL4 panel

COL4A1, COL4A2

157

31,842

23

CACNA1A panel

CACNA1A

83

16,837

27

ATP1A2 panel

ATP1A2

57

10,244

15

  1. For each panel, the genes involved are reported, together with the total number of amplicons per panel and the dimension of the target regions in base pairs. For each panel, the number of sequenced samples is reported